TON July 2015 Vol 8 No 4

In this month’s issue of The Oncology Nurse-APN/PA (TON), we start our coverage of the news from the recent Oncology Nursing Society (ONS) 40th Annual Congress and the 2015 Annual Meeting of the American Society of Clinical Oncology (ASCO).
TON spoke with Carla Schaefer about the challenges and the rewards of working as a nurse manager at the Rutgers Cancer Institute of New Jersey, a leader in advanced comprehensive care and cancer research.
“As a CoC member, we look forward to joining forces with some of the nation’s foremost oncology organizations to help write and implement policy that ensures patients have access to the highest standard of care available for their cancer,” said Lillie Shockney, AONN+ program director.
At the ONS 2015 meeting, experts shared their clinical advice for addressing the barriers to HPV vaccination uptake among boys, girls, and young men and women.
One STAR program demonstrated how hospitals and health systems can meet the challenge of delivering high-quality cancer rehabilitation services that improve patient outcomes and satisfaction, yet fit into value-based delivery models.
The advent of imatinib (Gleevec; Novartis Pharmaceuticals) was considered a near miracle for the treatment of chronic myeloid leukemia (CML).
Pancreatic cancer represents 3% of new cancer cases each year, with the average age of diagnosis being 71 years.
The two most depressing times of my life were when I was first diagnosed with cancer and when I completed cancer treatment.
Palliative care is a key component of quality care. Oncology nurses have many of the skill sets for providing generalist quality care and are poised to play a major role in advocating and transforming palliative care for patients with cancer.
The 2015 Annual Congress of the Oncology Nursing Society (ONS) marks the 40th anniversary of the organization. Presentations and events included the new and the “tried and true.”
Page 1 of 2
Results 1 - 10 of 14